Adial Pharmaceuticals Inc (ADIL)

[barnyarddog]

PAST NEWS
Sep-30-20 09:25AM
Adial Pharmaceuticals Announces Sale of 10,000 COVID-19 Antibody Rapid Test Devices
ACCESSWIRE -26.40%
Sep-29-20 09:30AM
Adial Pharmaceuticals Announces COVID-19 Point-of-Care Antibody Test Granted First Ever FDA Emergency Use Authorization for Use with Fingerstick Blood Samples
ACCESSWIRE +114.89%
Sep-25-20 10:00AM
Adial Pharmaceuticals Files for Expedited Review of AD04 with the FDA
ACCESSWIRE
Sep-22-20 09:30AM
Adial Pharmaceuticals and iRemedy Partner to Sell COVID-19 Antibody Test Kits to U.S. Medical Providers and Commence Sales
ACCESSWIRE
Sep-09-20 09:00AM
Adial Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 16th
ACCESSWIRE
Sep-01-20 07:22PM
Adial Pharmaceuticals to Present at The LD Micro 500 Virtual Conference on September 2nd
ACCESSWIRE +8.70%
Aug-31-20 05:00PM
LD Micro - 360 Companies Set to Present this Week
ACCESSWIRE
Aug-06-20 09:30AM
Adial Pharmaceuticals Announces Third-Party Sales and Distribution Agreement with Brik for Rapid Result COVID-19 Antibody Test Kits
ACCESSWIRE +14.97%
Aug-05-20 09:00AM
LD Micro Announces Preliminary List of Presenters for the LD 500
ACCESSWIRE
Jul-28-20 09:30AM
Adial Pharmaceuticals Schedules Business and Clinical Update Conference Call
ACCESSWIRE
Jul-22-20 09:45AM
Adial Pharmaceuticals Receives European Medicines Agency (EMA) Agreement on the Pediatric Investigation Plan (PIP) for AD04 in Alcohol Use Disorder
ACCESSWIRE
Jul-06-20 08:15AM
Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD(TM) Pivotal Phase 3 Trial in Sweden and Estonia
ACCESSWIRE
Jun-25-20 09:30AM
Adial Pharmaceuticals Announces Commencement of Landmark ONWARD(TM) Pivotal Phase 3 Trial in Poland
ACCESSWIRE +5.71%
Jun-17-20 09:55AM
Adial Pharmaceuticals Announces Commencement of the Landmark ONWARD(TM) Pivotal Phase 3 Clinical Trial in Latvia
ACCESSWIRE
Jun-15-20 09:30AM
Adial Pharmaceuticals Closes Previously Announced $5.2 Million Registered Direct Offering
ACCESSWIRE
Jun-11-20 11:35AM
Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD(TM) Pivotal Phase 3 Trial in Poland
ACCESSWIRE -7.01%
Jun-10-20 10:06AM
Adial Pharmaceuticals Receives Order for 1,000 COVID-19 Antibody Test Kits
ACCESSWIRE +8.28%
Jun-09-20 09:15AM
Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market
ACCESSWIRE -28.57%
Jun-08-20 09:30AM
Adial Pharmaceuticals and BioLab Sciences Enter into Distribution Agreement for COVID-19 Antibody Tests
ACCESSWIRE +18.00%
May-28-20 09:30AM
Adial Pharmaceuticals Appoints Dr. Jack Reich to Board of Directors
ACCESSWIRE
May-04-20 10:15AM
Op-Ed by Adial Pharmaceuticals CEO Published in the Daily Progress
ACCESSWIRE
Apr-23-20 08:45AM
Adial Pharmaceuticals Files Post-Effective Amendments to Registration Statements For Outstanding Shares Underlying Existing Warrants and Shelf Registration Statement to Provide Financial Flexibility
ACCESSWIRE
Apr-16-20 10:17AM
Adial Pharmaceuticals Verifies Proprietary Genetic Test in Landmark ONWARD(TM) Pivotal Phase 3 Clinical Trial
ACCESSWIRE +18.84%
Apr-15-20 09:45AM
Adial Pharmaceuticals Issued Second Patent Covering AD04 as a Treatment for Opioid Use Disorder
ACCESSWIRE
Apr-09-20 09:30AM
Adial Pharmaceuticals Provides Update on ONWARD(TM) Phase 3 Pivotal Trial
ACCESSWIRE
Mar-29-20 08:19AM
Will Adial Pharmaceuticals (NASDAQ:ADIL) Spend Its Cash Wisely?
Simply Wall St.
Mar-26-20 09:15AM
Adial Pharmaceuticals Receives Issue Notification for Patent Covering AD04 for the Treatment of Opioid Use Disorder
ACCESSWIRE
Mar-17-20 09:30AM
Adial Pharmaceuticals Announces Modifications to the Phase 3 Pivotal Trial of AD04 to Protect Subjects from COVID-19
ACCESSWIRE